header
 

banner rdc

---------------------------------

The Pharmacist e-Link™ Continuing Education Center is designed to provide you with expanded online access to the highest quality of continuing education on a complimentary basis, through the convenience of the Velocity™ Online Learning Management System.


---------------------------------

banner norvasc

---------------------------------

Need Help logging into the Pharmacicst e-Link site?
Click Here for Registration and
Login Information

---------------------------------



banner rdc

This system allows you to search for relevant content from today’s leading providers in the world of continuing education, maintain your personal curriculum, bank your continuing education credits (both online and offline) track and print your professional transcript and more…


bullet Pharmacist e-Link CE Spotlight

thumbnail

Medicare Rx Forum:
A Briefing and Town Hall Discussion on the
New Prescription Drug Benefit

The Medicare Modernization Act of 2003 (MMA) will have an enormous effect on community pharmacy. This informative program will prepare the community pharmacist with the vital information they need to educate their customers to the effects the MMA will have on their lives and how to best deal with Medicare Part D.


thumbnail Novel Therapies to Reduce Cardiometabolic Risk Factors
The goal of this program is to discuss the emerging therapies on the horizon to reduce risk factors associated with metabolic syndrome. The program faculty will demonstrate the need for disease management solutions to improve cardiovascular health and the importance of early treatment to prevent or minimize the under managed cardiometabolic risk factors associated with metabolic syndrome.
This program is supported through an educational grant from Sanofi-Aventis.

bullet Other Featured CE

thumbnail Self-Care Management for the Diabetic Patient: Focus on Skin and Nutrition
The goal of this educational activity is to provide an overview of diabetes self-care in the areas of skin care and nutrition. It has been designed for all pharmacists who interact and provide counseling to patients with diabetes.
This program is supported through an educational grant from Health Care Products.

thumbnail New Approaches and Patient Counseling in the Treatment of Osteoporosis
Osteoporosis will create a significant problem with severe lifestyle impact to one in two women and one in four men over 50 years of age — many of your pharmacy patients. This program brings you insight to treatment of this patient population.
Commercial Support Provided by Roche Laboratories Inc. and GlaxoSmithKline

thumbnail The Pharmacist's Role in the Medication Therapy Management of Chronic Pain
Managing your patients with chronic pain is critical to ensuring the best patient outcomes. This session will bring you vital information you need to know to give these pharmacy patients the best possible care and greatly improve their quality of life.
This program is supported by an educational grant from Purdue Pharma L.P.

thumbnail The Skinny on Fatty Acids: The Efficacy of Omega-3s
The purpose of this activity is to provide information regarding available types and sources of omega-3 fatty acids. These include over the counter plant-and fish oil-based supplements and a newly approved prescription product. It is important that pharmacists are aware of the appropriate treatment options when advising patients with hypertriglyceridemia or those otherwise at risk for coronary heart disease.
This program is supported by an educational grant from Reliant Pharmaceuticals.

thumbnail National Peer Reviews in Cancer Supportive Care: New Directions in Preventing Febrile Neutropenia
This activity is designed to update healthcare professionals on the latest clinical advances in the management of febrile neutropenia.
This program is supported by an educational grant from Amgen.

thumbnail Every Breath You Take: Moving Towards Better COPD Management
It is estimated that chronic obstructive pulmonary disease affects 16 million Americans, and the direct and indirect annual cost of the disease is approximately 32 billion dollars. COPD is currently considered to be the fourth leading cause of death in the USA, and it is the only one in the top 5 causes of death that continues to increase annually.
This program is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer, Inc.